Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
CRISPR
Pharma
Michigan Medicaid signs deal with bluebird for SCD gene therapy
Bluebird Bio has secured its first Medicaid outcomes-based agreement for its sickle cell disease gene therapy Lyfgenia, signing on with Michigan.
Kevin Dunleavy
Mar 11, 2024 11:00am
'The Top Line': Gene editing's next act
Feb 16, 2024 8:55am
Vertex's sales of Trikafta hit $8.9B thanks to label expansion
Feb 6, 2024 12:39pm
J&J lands two cancer drugs on Clarivate list of notable new meds
Jan 17, 2024 1:19pm
FDA approves Vertex, CRISPR's Casgevy for beta thalassemia
Jan 16, 2024 3:40pm
In 'historic' nod, UK signs off on Vertex, CRISPR's gene therapy
Nov 16, 2023 11:45am